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Previously, we have demonstrated that the tyrosine phosphorylated hepatocyte growth factor
receptor (Met) binds to the c-Cbl phosphotyrosine-recognition, tyrosine kinase binding (TKB)
domain in a reverse orientation compared to other c-Cbl binding partners. A Met peptide with
the DpYR motif changed to RpYD (MetRD) retains a similar TKB binding afﬁnity as the native Met
peptide. However, the TKB: MetRD complex crystal structure reveals a complete reversal of the bind-
ing orientation. Collated data indicates that both binding and orientation is dictated by the phos-
phorylated tyrosine and an adjacent arginine forming intra-peptide hydrogen bonds and aligning
unidirectionally with complementary charges in the phosphotyrosine binding pocket of c-Cbl.
Structured summary:
c-Cbl and MetRD bind: shown by x-ray crystallography (view interaction)
c-Cbl and MetRD bind: shown by mass spectrometry studies of complexes (view interaction)
c-Cbl bind to Met: shown by surface plasmon resonance (view interactions 1,2)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction speciﬁc to each SH2 domain contained within different proteinsThe casitas B-lineage lymphoma (Cbl) family of proteins, epito-
mized by c-Cbl, has a well-documented role in a number of aspects
of cell signaling. Cbl was ﬁrst known as a scaffold protein and
thereafter characterized as a Ubiquitin E3 ligase [1,2]. It plays a
major role in the downregulation of a number of receptor and
non-receptor tyrosine kinases. Cbl proteins have multiple domains
and have been demonstrated to interact with a number of other
proteins via proline-rich sequences and phosphotyrosine residues
[3]. To enable its role in the ubiquitin-targeting system, Cbl con-
tains a novel embedded Src homology 2 (SH2) domain that recog-
nizes particular phoshotyrosine containing sequences on target
proteins [4].
SH2 domains are well-characterized phosphotyrosine recogniz-
ing domains that seemed to co-evolve with tyrosine phosphoryla-
tion in metazoans, with relatively strict recognition sequenceschemical Societies. Published by E
Src homology 2; SPR, surface
r receptor; Met, hepatocyte
ma
.R. Guy), +65 6779 5671 (J.
Guy), dbsjayar@nus.edu.sg (J.[5]. The association of 4H and EF domains with the SH2 domain
on Cbl, however, appears to be unique. It was somewhat surprising
that the embedded SH2 domain of Cbl appeared to have a rather
wide speciﬁcity in sequence recognition. We recently addressed
the question as to how the Cbl tyrosine kinase binding (TKB) do-
main could recognize a ‘consensus’ sequence (N/D)XpY(S/T)XXP
as well as an apparently unrelated DpYR sequence [6]. We demon-
strated that in recognizing the DpYR sequence on the hepatocyte
growth factor receptor (Met), Cbl ﬂips over to bind in a reverse ori-
entation relative to targets with the canonical sequence. Binding
afﬁnity and perhaps orientation were mediated by an intrapeptidyl
bond between the phosphorylated tyrosine residue and an adja-
cent Arg or a nearby Asp residue [7]. It is noteworthy that the epi-
dermal growth factor receptor (EGFR), a well characterized Cbl
target, had an Arg in the pY1 position that would resemble the
DpYR motif found in the Met family of receptors, but in a reversed
direction. The EGFR sequence also contained a pY+1 Ser and pY+4
Pro unlike Met’s sequence.
We asked the question in this study: what determines the ori-
entation of target peptides binding to the Cbl TKB domain? To
accomplish this, we took the most minimal DpYR Met binding se-
quence and tested the binding of derivative peptides and crystal-
lized candidates that bound, in order to understand factors
governing binding motif orientation of the Cbl-TKB.lsevier B.V. All rights reserved.
Table 2
Crystallographic reﬁnement statistics of c-Cbl:MetRD complex.
Data set c-Cbl:MetRD
Data collection*
Cell parameters (Å, ) a = 52.7, b = 104.5, c = 60.6,
b = 90.2
Space group P21
Resolution range (Å) 50–1.92 (1.99–1.92)
Wavelength (Å) 1.5418
Observed reﬂections 187 613
Unique reﬂections 48 545
Completeness (%) 97.6 (92.5)
Overall (I/rI) 13.3 (3.1)
Rsym
a (%) 0.065 (0.203)
Solvent content (%) 61
Reﬁnement statistics
Resolution range (Å) 20–1.92
Rwork
b (no. of reﬂections) 0.159 (43 601)
Rfree
c (no. of reﬂections) 0.180 (2462)
RMSD bond lengths (Å) 0.022
RMSD bond angles () 1.627
No. of protein atoms/ligand atoms/water
molecules
4942/80/575
B-factors (Å2)
Average B-factors of protein atoms 29.2
Rms B-factor of protein atoms 1.8
Average B-factors of ligand atoms 34.1
Rms B-factor of ligand atoms 3.3
Average B-factors of water atoms 33.6
Ramachandran plot
Most favored regions (%) 99.4
Generously allowed regions (%) 0.6
Disallowed regions (%) 0.0
a Rsym =
P jIi  hIij=
P jIi j, where Ii is the intensity of the ith measurement, and hIi
is the mean intensity for that reﬂection.
b Rwork =
P jFobs  Fcalcj=
P jFobsj, where Fcalc and Fobs are the calculated and
observed structure factor amplitudes, respectively.
c Rfree = as for Rwork, but for 5.0% of the total reﬂections chosen at random and
omitted from reﬁnement for all datasets.
* Statistics for the high resolution bin.
282 Q. Sun et al. / FEBS Letters 585 (2011) 281–2852. Materials and methods
We have designed two peptides based on the sequence of wild
type Met (MetWT), (1) by reversing core residues of the peptide
(hereafter referred as MetRD) and (2) by changing pYRA residues
of MetWT peptide to pYAN (hereafter referred as MetN) (Table 1).
These peptideswere purchased fromGL Biochem (Shanghai, China).
2.1. Biophysical interaction studies
Surface plasmon resonance (SPR) experiments were performed
with Biacore 3000 (Biacore AB, Uppsala, Sweden). c-Cbl protein
(50 ng/lL in 5 mM sodium citrate pH 6.5) was immobilized onto a
CM5 Chip as per themanufacturer’s recommendations. The running
buffer consistedof 20 mMNaHepespH7.0 and200 mMNaCl.Differ-
ent concentrations of peptides (300 nM to 27 lM in running buffer)
were applied to the chip surface at a ﬂow rate of 20 ll/min at 25 C.
Regenerationusing runningbufferwash for2 minresulted ina stable
baseline corresponding to the starting baseline level. Reference cells
are immobilized with inactive c-Cbl TKB domain resulting from
1 min ﬂow of 10 mM H2SO4 through the cell. The equilibrium con-
stant (Kd)wasdeterminedby the1:1Langmuirbindingﬁttingmodel
provided by the Biacore 3000 instrument software.
2.2. Complex formation, crystallization and structure determination
Cloning, expression and puriﬁcation of c-Cbl was performed as
described previously [6]. Phosphopeptides were reconstituted in
20 mMHepes, 200 mMNaCl and pH 7.0.MetRDwas incubatedwith
puriﬁed c-Cbl TKB in ﬁvefold molar excess, and concentrated to
5 mg/ml using Amicon ultraﬁltration devices (Millipore, Billerica,
MA). TKB: MetRD complex crystallized in 100 mM Bis–tris propane
pH 6.5, 50 mM ammonium sulfate by mixing 1 ll of reservoir solu-
tionwith 2 ll of protein using hanging drop vapor diffusionmethod
at room temperature. The mother liquor supplemented with 10%
glycerol as cryo-protectant. The X-ray diffraction datawas collected
using in-house Bruker X-8 PROTEUM system and processed with
HKL2000 [7]. The structure was solved by using molecular replace-
ment method with the program MolRep [8] using c-Cbl–TKB do-
main as a search model (pdb code: 3BUX). The resulting model
with the electron density map was examined in the program COOT
[9], and necessary manual model building was performed. Several
cycles of map ﬁtting and alternated with reﬁnement using the pro-
gram Refmac5 [10] led to the convergence of R-values (Table 2).
2.3. Protein databank accession code
Coordinates and structure factors of the MetRD: Cbl-TKB com-
plex was deposited at RCSB Protein Data Bank with the code 3PLF.
3. Results and discussion
A peptide from the Cbl–TKB atypical binding motif (DpYR) in
the Met receptor (MetWT) chosen in our previous study was crys-Table 1
Comparison of binding parameters for the interactions between c-Cbl and the
phosphorylated peptides.
Peptide Sequence kon (M1 s1) koff (s1) Kd (lM) v2
MetWT SNESVDpYRATFPE 2.7  105 1.17 4.4 1.55
MetRD SNESVRpYDATFPE 2.0  105 1.38 6.7 0.42
MetN SNESVDpYANTFPE No binding
v2 is the statistical error between the experimental and theoretical models. v2 is
deﬁned as R(Rf  Rx)2/(n  p), where Rf is the ﬁtted value at a given point, Rx is the
experimental value at the same point, n is the number of data points, and p is the
number of ﬁtted parameters.tallised in complex with the Cbl–TKB domain [6]. This peptide had
the sequence SNESVDpYRATFPE, and bound in a reverse direction
on the TKB domain relative to other peptides of the typical binding
motif [NXpY(S/T)XXP]. In an initial experiment to determine fac-
tors responsible for the orientation reversal of the Met atypical se-
quence, two more peptides: (1) SNESVRpYDATFPE (MetRD), where
conserved residues ﬂanking the phosphorylated tyrosine were re-
versed, (2) SNESVDpYANTFPE (MetN) where the conserved argi-
nine in the wildtype sequence was replaced by alanine, were
constructed.
The afﬁnities of these peptides binding to the TKB domain were
assessed by SPR and the data obtained is shown in Table 1 and
Fig. 1. Two distinct observations were apparent: (1) The MetRD
binding afﬁnity was similar to the wildtype peptide afﬁnity, and
(2) no binding was observed when the conserved arginine in the
wild type Met sequence was substituted by alanine. It was previ-
ously determined that the minimum TKB binding sequence for
MetWT is DpYR, suggesting little contribution by any other resi-
dues ﬂanking the DpYR motif. The lack of binding of the MetN pep-
tide to the TKB domain indicates that the conserved arginine is
essential for binding and possibly orientation of the peptide. While
the MetRD and MetWT peptides bind with similar afﬁnity, we did
not know the structural changes implicated by reversal of the
DpYR motif in the MetRD peptide.
To ascertain the binding orientation of MetRD and to investigate
its mode of binding to the Cbl-TKB, we proceeded to crystallize the
MetRD: Cbl-TKB complex and compared it with the previously
determined MetWT: Cbl-TKB structure [6]. The c-Cbl-TKB: MetRD
complex was crystallized in P21 spacegroup with two complex
molecules in an asymmetric unit. The structure was reﬁned to a
Fig. 1. SPR analysis of peptides binding to TKB domain. (A) MetWT and (B) MetRD
binding to c-Cbl TKB domain at different concentrations (repeated twice). (C) MetN
does not bind to TKB domain. MetWT curve (10 lM) is superimposed on MetN
(10 lM) curve for comparison. Shown are raw curves after subtracting from the
reference ﬂow cell. The y axis shows the response unit (RU) and the x axis shows the
time (s). The kinetic values are listed in Table 1.
Fig. 2. Crystal structure of TKB: MetRD complex. (A) Ribbon diagram of the TKB:
MetRD. N- and C- termini are labeled. c-Cbl-TKB is in green color. MetRD (magenta)
peptide is shown in stick representations. (B) Stereo-view of the 2Fo  Fc simulated
annealing omit map of MetRD peptide. All atoms within 3.5 Å of the peptide were
omitted prior to reﬁnement. Map is contoured at a level of 1.0r. These and the
following ﬁgures were prepared using the program PyMol [11].
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(RpYDA) of MetRD peptide were clearly observed in the electron
density map. The remaining residues of this peptide were disor-
dered in the crystal. The mass spectrometric experiment on these
crystals conﬁrmed the presence of intact 13mer peptide in the
complex crystal (Supplementary Fig. 1).
When MetRD: Cbl-TKB was superimposed with MetWT: Cbl-
TKB (Fig. 3A), the phosphotyrosines of both peptides occupy the
same pocket on the TKB domain in the same orientation, with
the side chains of phosphotyrosine and arginine from the two com-
plexes well superimposed. However, MetRD binds in the reverse
direction compared with MetWT such that the N- and C-terminusof the MetWT and the MetRD peptide are 180 rotated with respect
to each other. Closer examination of MetRD and MetWT reveal that
the peptide backbones do not match well. All residues of the Met-
RD peptide are almost linear while the MetWT peptide is bent
approximately 90 about the phosphotyrosine. Although orienta-
tion of the peptides are different, the same residues from c-
Cbl-TKB, namely Ser80, Pro81, Tyr274, Ser296, Arg294, Cys297,
Thr298 and Gln316 are involved in binding (Fig. 3A, Table S1). If
the EGFR (DSFLQRpYSSDPTG), MetWT and MetRD peptides are
compared, it appears that the position of the conserved arginine
residue dictates directionality of binding to the TKB.
Electrostatic surface potential shows that the charge distribu-
tion of the phosphotyrosine binding pocket is an important factor
in orientating the conserved residues (Fig. 3B and C). pTyr1003
binds to a highly positively charged region while Arg1002 binds
to a negatively charged region as indicated by the arrows in
Fig. 3B. Arg294 of c-Cbl forms a salt bridge with phosphate group
of pTyr1003 while the Ser80 side chain hydroxyl group and
Pro81 backbone carbonyl group interact with Arg1002. In all of
the TKB complex structures determined so far, the tyrosine ring
of the phosphotyrosine is part of a large hydrophobic cluster,
Fig. 3. Determinants of peptide binding orientation. (A) Superimposition of MetWT
(green) versus MetRD (magenta) complexes. Peptides are shown in stick represen-
tation, and c-Cbl TKB domain is shown in line representation. Hydrogen bonds are
shown in dashed lines. The SH2 domain (84 Ca atoms) of the TKB from both
complexes was superimposed with an rmsd of 0.17 Å. (B) The electrostatic surface
potential at the region where the phosphorylated peptide binds to the c-Cbl TKB
domain. The ball and stick representation shows the MetRD peptide. The yellow
arrow shows the positive and negatively-charged region on c-Cbl that may prevent
the phosphotyrosine and arginine from reversing positions in the cleft. (C) Cross
sectional, enlarged view of (B). The scaling of the electrostatic potential is ±10 kT for
both electrostatic surface potential representations.
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these observations, we suggest that charge distribution and spatial
architecture of the phosphotyrosine binding pocket collectively di-
rect the DpYR conserved residues to be able to bind only in one ori-
entation, with the phosphotyrosine speciﬁcally interacting with
Arg294.
From this and the previous study [6], it is apparent that se-
quences derived from Cbl–TKB binding partners dictate both the
afﬁnity and orientation of the interacting moieties. These facets
of binding are determined by: (1) key residues that insert into
the phosphotyrosine binding pocket and (2) accessory residues
(other than pY or pY±1 residues, e.g. well-conserved Pro at pY+4
position) that contact the surrounding TKB surface. Because these
accessory residues are not apparent in the electron density map
of the TKB: MetRD complex structure, we conclude they are not
critically important in determining binding and binding orienta-
tion. Although the entire peptide orientation is reversed in MetRD,
the positions of Arg1002 and pTyr003 remain unchanged in the
phosphotyrosine binding pocket of c-Cbl-TKB relative to MetWT.
It appears that in the case of MetWT binding to TKB, both the bind-
ing strength and the orientation are primarily determined by the
interaction of the phosphotyrosine and the adjacent arginine resi-
due via their intrapeptide bond. It is noteworthy that there was
contribution to binding afﬁnity by other conserved amino acids
in peptides conforming to the ‘canonical’ c-Cbl TKB sequence; N/
DXpYS/TXXP tested previously. The ‘theoretical’ MetRD and MetN
peptides used in this study enabled us to determine factors that
determine the orientation of c-Cbl on the Met receptor. These se-
quences are not likely to exist in cells but are useful tools to study
biophysical properties of Cbl–TKB: substrate interaction. While we
have also referred to the substrate peptide changing its orientation,
it would be more plausible that the cytoplasmic c-Cbl changes ori-
entation instead in comparison to other receptors such as the
EGFR, while binding to the transmembrane c-Met receptor in cells.
Collated data from this and our recent studies demonstrates
that the only necessary binding and orientation elements required
in a Cbl–TKB target are N/DXpY or RpY. Other residues deemed to
be conserved in some families of TKB recognition sequences, such
as the +4 Proline in the previously designated ‘typical’ binding se-
quence only add to the strength of binding. If the sequence is pYR
the binding will reverse to essentially become in effect RpY.
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